PNC Financial Services Group
ORIC icon

PNC Financial Services Group’s Oric Pharmaceuticals ORIC Stock Holding History

PNC Financial Services Group’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,010
Closed -$101K – 5313
2026
Q1 		$101K Sell
8,010
-1,046
-12% -$11.9K ﹤0.01% 2810
2025
Q4 		$74.1K Sell
9,056
-112
-1% -$1.29K ﹤0.01% 2994
2025
Q3 		$110K Sell
9,168
-3,319
-27% -$34.9K ﹤0.01% 2746
2025
Q2 		$127K Buy
12,487
+897
+8% +$6.02K ﹤0.01% 2536
2025
Q1 		$64.7K Sell
11,590
-1,927
-14% -$16.8K ﹤0.01% 2946
2024
Q4 		$109K Buy
13,517
+2,520
+23% +$23.1K ﹤0.01% 2631
2024
Q3 		$113K Buy
10,997
+237
+2% +$2.34K ﹤0.01% 2589
2024
Q2 		$76.1K Buy
+10,760
New +$96.3K ﹤0.01% 2794

Other funds holding ORIC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

PNC Financial Services Group's ORIC Position: Q2 2026 in Review

PNC Financial Services Group sold out of Oric Pharmaceuticals (ORIC) in Q2 2026, closing a stake of 8,010 shares — an estimated $101K sold.

PNC Financial Services Group first reported a position in ORIC in Q2 2024 and held it in 8 quarters. The position peaked at $127K in Q2 2025. 56 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • PNC Financial Services Group reported no remaining Oric Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • PNC Financial Services Group sold 8,010 Oric Pharmaceuticals shares in Q2 2026, an estimated $101K.
  • PNC Financial Services Group first reported a position in Oric Pharmaceuticals in Q2 2024 and held it in 8 quarters.
  • PNC Financial Services Group's Oric Pharmaceuticals position peaked at $127K in Q2 2025.
  • 56 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.